Simplifying Menstrual Regulation (MR): Post Abortion Care in Pakistan

Simplifying Menstrual Regulation (MR): Exploring the Role of At-home Semi-quantitative Pregnancy Tests for Follow-up to Menstrual Regulation Service Provision in Pakistan: Post Abortion Care (PAC)

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02343913

Enrollment

329

Registered

2015-01-22

Start date

2014-06-30

Completion date

2014-12-31

Last updated

2015-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Medical Abortion

Brief summary

This study is an additional component of protocol 6005, titled Simplifying Menstrual Regulation (MR): Exploring the role of at-home semi-quantitative pregnancy tests for follow-up to menstrual regulation service provision in Pakistan. The study seeks to pilot a self-assessment checklist that will help women, who receive medical services for incomplete abortion, correctly identify warning signs and symptoms and determine whether to return to the clinic. The checklist can serve as a useful resource to help with the timely identification of women who need additional care and can help streamline service delivery. In addition, this study will provide important data on the role of misoprostol at varying levels of health services offering an array of treatments for incomplete abortion.

Interventions

DEVICEPAC checklist

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Healthy volunteers

Yes

Inclusion criteria

* Vaginal bleeding during pregnancy * Open cervical os. * No signs of severe infection, defined as at least one of the following of: 1) foul smelling discharge, 2) fever \> 38 degrees C , 3) uterine tenderness * No hemodynamic disturbances (pulse \>110/min and systolic bp \<100)

Exclusion criteria

* Suspected to have an ectopic pregnancy * Unable to provide informed consent

Design outcomes

Primary

Measure	Time frame	Description
Identify symptoms	1 week	Proportion of women able to use a checklist to correctly identify any signs and symptoms that warrant immediate return to the clinic and additional care

Secondary

Measure	Time frame	Description
Acceptability of treatment	1 week	Proportion of women who find the treatment of 400 sublingual misoprostol for incomplete abortion acceptable and satisfactory.
Uptake of contraceptive use	1 week	Proportion of women who receive a contraceptive method after receipt of 400 sublingual misoprostol

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026